Ethic Inc. Has $2.74 Million Holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Ethic Inc. lifted its holdings in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) by 47.6% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 35,012 shares of the company's stock after purchasing an additional 11,295 shares during the quarter. Ethic Inc.'s holdings in GE HealthCare Technologies were worth $2,737,000 as of its most recent SEC filing.

Other hedge funds also recently made changes to their positions in the company. CoreFirst Bank & Trust bought a new position in GE HealthCare Technologies in the fourth quarter valued at approximately $25,000. Runnymede Capital Advisors Inc. bought a new stake in shares of GE HealthCare Technologies in the fourth quarter worth $28,000. LGT Financial Advisors LLC grew its stake in shares of GE HealthCare Technologies by 46.2% in the fourth quarter. LGT Financial Advisors LLC now owns 389 shares of the company's stock worth $30,000 after purchasing an additional 123 shares during the last quarter. Accredited Wealth Management LLC bought a new stake in GE HealthCare Technologies during the fourth quarter valued at $30,000. Finally, Bank of Jackson Hole Trust bought a new stake in GE HealthCare Technologies during the fourth quarter valued at $32,000. 82.06% of the stock is owned by institutional investors.

GE HealthCare Technologies Trading Down 0.9%

NASDAQ:GEHC opened at $69.87 on Monday. The firm has a 50-day moving average price of $72.49 and a two-hundred day moving average price of $80.58. The company has a debt-to-equity ratio of 0.88, a quick ratio of 0.83 and a current ratio of 1.04. GE HealthCare Technologies Inc. has a 52 week low of $57.65 and a 52 week high of $94.80. The firm has a market cap of $31.99 billion, a price-to-earnings ratio of 16.14, a price-to-earnings-growth ratio of 3.19 and a beta of 1.21.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last released its quarterly earnings data on Wednesday, April 30th. The company reported $1.01 EPS for the quarter, topping the consensus estimate of $0.91 by $0.10. GE HealthCare Technologies had a net margin of 10.13% and a return on equity of 25.74%. The company had revenue of $4.78 billion during the quarter, compared to the consensus estimate of $4.66 billion. During the same period last year, the firm earned $0.90 EPS. GE HealthCare Technologies's revenue for the quarter was up 2.7% on a year-over-year basis. On average, equities analysts expect that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current fiscal year.

GE HealthCare Technologies Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, May 15th. Stockholders of record on Friday, April 25th will be issued a dividend of $0.035 per share. This represents a $0.14 dividend on an annualized basis and a dividend yield of 0.20%. The ex-dividend date of this dividend is Friday, April 25th. GE HealthCare Technologies's dividend payout ratio is currently 2.95%.

GE HealthCare Technologies announced that its board has authorized a stock repurchase program on Wednesday, April 30th that allows the company to repurchase $1.00 billion in shares. This repurchase authorization allows the company to repurchase up to 3.1% of its shares through open market purchases. Shares repurchase programs are usually a sign that the company's leadership believes its stock is undervalued.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently issued reports on GEHC shares. Evercore ISI cut their price objective on shares of GE HealthCare Technologies from $96.00 to $85.00 and set an "outperform" rating on the stock in a research report on Thursday, May 1st. Piper Sandler cut their price objective on shares of GE HealthCare Technologies from $104.00 to $88.00 and set an "overweight" rating on the stock in a research report on Wednesday, April 23rd. Citigroup lowered their target price on shares of GE HealthCare Technologies from $105.00 to $86.00 and set a "buy" rating on the stock in a report on Wednesday, April 30th. BTIG Research set a $95.00 target price on shares of GE HealthCare Technologies and gave the stock a "buy" rating in a report on Monday, April 14th. Finally, UBS Group upgraded shares of GE HealthCare Technologies from a "sell" rating to a "neutral" rating and lowered their target price for the stock from $74.00 to $73.00 in a report on Monday, May 5th. Three equities research analysts have rated the stock with a hold rating, eight have assigned a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average target price of $88.27.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.